• Increase
  • Decrease
  • Normal

GMP Solutions

MolMed GMP Solutions provides tailor-made services for your cell & gene therapy projects.

Investor kit

MolMed online Investor kit delivers all the financial documents and usefull tools to monitor the share performance. To order printed materials, or request additional investor-related information, complete the Investor contact form.

MolMed S.p.A. is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer.

Products of excellence

Last presentation

Jun 2, 2014 - Jun 5, 2014
Company presentation,Jefferies conference,NYC,june 5,2014

Financial reports

Annual financial report (in Italian) 2014
Annual financial report (in Italian)
Half year financial report (in Italian) at 06/30/2015
Half year financial report (in Italian)
Financial report (in Italian) at 03/31/2015
Interim financial report (in Italian) at 09/30/2014
Half-year financial report (in Italian) at 06/30/2014
Interim financial report (in Italian) at 03/31/2014
Quarterly financial report (in Italian) at 09/30/2013

MolMed S.p.A. Via Olgettina, 58 - 20132 Milano, Italy | Phone +39 0221277.1 - Fax +39 02 21277.325 | -
Share capital € 19,841,682.30 fully paid - Office of Milan Company Registry number 1506630 - Tax identification number 11887610159